Detalhe da pesquisa
1.
Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry.
Blood Cancer J
; 14(1): 50, 2024 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38499538
2.
Flow cytometric protein expression profiling as a systematic approach for developing disease-specific assays: identification of a chronic lymphocytic leukaemia-specific assay for use in rituximab-containing regimens.
Leukemia
; 20(12): 2102-10, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17051247
3.
A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study.
Leukemia
; 30(4): 929-36, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26639181
4.
A single-tube six-colour flow cytometry screening assay for the detection of minimal residual disease in myeloma.
Leukemia
; 21(9): 2046-9, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17657223
5.
Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL.
Leukemia
; 27(1): 142-9, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23041722
6.
Monoclonal B-cell lymphocytosis (MBL) in CLL families: substantial increase in relative risk for young adults.
Leukemia
; 20(4): 728-9, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16437141
7.
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols.
Leukemia
; 26(9): 1986-2010, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22948490
8.
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.
Leukemia
; 26(9): 1908-75, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22552007
9.
Heterogeneity of histological transformation events in Waldenström's macroglobulinemia (WM) and related disorders.
Clin Lymphoma Myeloma Leuk
; 11(1): 176-9, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21856554
10.
Anti-CD22-MCC-DM1: an antibody-drug conjugate with a stable linker for the treatment of non-Hodgkin's lymphoma.
Leukemia
; 24(9): 1566-73, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20596033